Ritlecitinib PF-06651600 CAS 1792180-81-4 C₁₅H₁₉N₅O, 285.34, UNII-2OYE00PC25 Fda approved  Litfulo, 6/23/2023, To treat severely patchy hair lossDrug Trials Snapshot 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one  1-[(2S,5R)-2-Methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-2-propen-1-one malonate PF-06651600 malonateCAS: 2140301-97-7 (malonate)Chemical Formula: C18H23N5O5 Molecular Weight: 389.412 PHASE 2  alopecia areata, rheumatoid arthritis, Crohn’s disease, and ulcerative colitis. Ritlecitinib, sold under the brand name Litfulo, is a medication used for the treatment of severe alopecia areata (hair loss).[6] Ritlecitinib is a kinase … Continue reading Ritlecitinib, PF 06651600